Abstracts Archive - Page 1031 of 2425 - ACR Meeting Abstracts

Abstract Number: 395 • 2018 ACR/ARHP Annual Meeting
Systemic Lupus Erythematosus (SLE) with Inflammatory Myositis
Nicole Bitencourt, Elizabeth (Blair) Solow and Bonnie L. Bermas, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX
Background/Purpose: The goal of this study was to identify specific clinical features of patients with SLE who have inflammatory myositis. Methods: A retrospective chart review…
Abstract Number: 396 • 2018 ACR/ARHP Annual Meeting
Clinical, Physiologic, and Radiologic Features Associated with Severe MDA5-Associated Interstitial Lung Disease
Tracy Doyle¹, Priya Borker², Elaine Fletcher¹, David Murphy³, Rachna Madan³ and Paul F. Dellaripa⁴, ¹Brigham and Women's Hospital, Boston, MA, ²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Boston, MA, ³Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Boston, MA, ⁴Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Autoantibodies against melanoma differentiation-associated protein 5 (MDA-5) have been described in patients with dermatomyositis (DM) and progressive interstitial lung disease (ILD). Previous cohorts have…
Abstract Number: 397 • 2018 ACR/ARHP Annual Meeting
Myositis-Specific Autoantibodies and Their Clinical Associations
Victor Tak Lung Wong¹, Ho So¹, Ricky Wai Ki Ip², Virginia W Lao³, Steve H Pang³, Lai-Shan Tam⁴, Priscilla Wong⁵, Lydia Ho Pui Tam⁶, Tsz On Lam⁷, Mei Yan Law⁸, Isaac CW Yim⁹, Tin Lok LAI¹⁰, Patrick Man Leung Lee¹¹ and Ronald Man Lung Yip¹², ¹Kwong Wah Hospital, Kowloon, Hong Kong, ²Queen Mary Hospital, Hong Kong, Hong Kong, ³Department of Medicine, Kwong Wah Hospital, Hong Kong, Hong Kong, ⁴Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, Hong Kong, Hong Kong, ⁵Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China, Hong Kong, China, ⁶Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁷Prince of Wales Hospital, New Territories, Hong Kong, ⁸Alice Ho Miu Ling Nethersole Hospital, New Territories, Hong Kong, ⁹Department of Medicine, Tseung Kwan O Hospital, Hong Kong, Hong Kong, ¹⁰Medicine, Tseung Kwan O Hospital, Tseung Kwan O, Hong Kong, ¹¹Yan Chai Hospital, Kowloon, Hong Kong, ¹²Tung Wah Group of Hospitals, Hong Kong, Hong Kong, Hong Kong
Background/Purpose: Myositis-specific autoantibodies (MSAs) have been shown to predict clinical features and have prognostic implications in patients with idiopathic inflammatory myopathies (IIMs), with anti-melanoma differentiation-associated…
Abstract Number: 398 • 2018 ACR/ARHP Annual Meeting
Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis
Kristofer Andreasson¹, Li Alemo Munters^1,2 and Helene Alexanderson^3,4, ¹Karolinska University Hospital, Function Area Occupational therapy and Physical therapy, Stockholm, Sweden, ²Swedish Rheumatism Association, Stockholm, Sweden, ³Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden, ⁴Function Area Occupational therapy & Physiotherapy, Allied Health Professionals Function, Karolinska University Hospital, Stockholm, Sweden
Background/Purpose: Poly- and dermatomyositis (PM/DM) are idiopathic inflammatory muscle diseases characterized by reduced muscle function. Oral glucocorticoids and DMARD’s are the usual treatment options and…
Abstract Number: 399 • 2018 ACR/ARHP Annual Meeting
Musculoskeletal Comorbidities after Total Knee Replacement for Osteoarthritis
MaryAnn Zhang¹, Faith Selzer², Elena Losina¹, Jamie E. Collins³ and Jeffrey N. Katz¹, ¹Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, ²Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA
Background/Purpose: For patients undergoing total knee replacement (TKR) for osteoarthritis (OA), preoperative musculoskeletal (MSK) complaints in areas beyond the index knee are common; however, the…
Abstract Number: 400 • 2018 ACR/ARHP Annual Meeting
Predictors of Response to a Single Intra-Articular Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid (HANOX-M-XL) in Patients with First Metatarsophalangeal Joint Osteoarthritis (hallux rigidus)
Thierry Conrozier¹, Aline Charpentier², Marie Bossert³, Sylvie Mellac-Ducamp⁴ and Laurent Galois⁵, ¹Department of Rheumatology,, Nord Franche-Comté Hospital, Belfort, France, ²Rheumatology, Nord Franche-Comté Hospital, Belfort, France, ³Rheumatology, Nord Franche Comté Hospital, Belfort, France, ⁴Rheumatology, Nevers General Hospital, Nevers, France, ⁵Orthopaedic and trauma surgery, University Hospital of Nancy, Nancy, France
Background/Purpose: To investigate the potential predictors of response to a single intra-articular injection of mannitol-modified cross-linked hyaluronic acid (HANOX-M-XL) in patients with first metatarsophalangeal joint…
Abstract Number: 401 • 2018 ACR/ARHP Annual Meeting
Quality of Systematic Reviews Comparing Conventional Vs. Computer-Assisted Joint Replacement
Mohamed Hasan¹, Manrui Zhang¹ and Hassan Ghomrawi², ¹Institute of Public Health and Medicine, Feinberg School of Medicine- Northwestern University, Chicago, IL, ²Surgery, and Center for Healthcare Studies, Feinberg School of Medicine- Northwestern University, Chicago, IL
Background/Purpose: An increasing number of total joint replacement (TJR) procedures are performed as computer-assisted total joint replacement (CA-TJR). Effectiveness of computer-assisted total joint replacement (CA-TJR)…
Abstract Number: 402 • 2018 ACR/ARHP Annual Meeting
Preoperative Physical Function Influences on Stair Climbing Ability 1 Month after Total Knee Arthroplasty
Jinseok Kim¹ and Bo Ryun Kim², ¹Department of Medicine, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South), ²Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South)
Background/Purpose: This study was undertaken to identify preoperative physical performance factors predictive of stair climbing ability 1 month following total knee arthroplasty. Methods: In this…
Abstract Number: 403 • 2018 ACR/ARHP Annual Meeting
Comparison of Radial Extracorporeal Shock Wave Therapy and Traditional Physiotherapy in Rotator Cuff Calcific Tendinitis Treatment
Tomris Duymaz¹ and Dilsad Sindel², ¹Physiotherapy and Rehabilitation, Istanbul Bilgi University, Faculty of Health Sciences, Istanbul, Turkey, Istanbul, Turkey, ²Department of Physical Medicine and Rehabilitation, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Radial Extracorporeal Shock Wave Therapy (rESWT) has more recently been used in the treatment of a number of musculoskeletal conditions. The purpose of this…
Abstract Number: 404 • 2018 ACR/ARHP Annual Meeting
Interleukin 17A– a Translational Target to Treat Supraspinatus Tendinopathy
Neal L Millar¹, Moeed Akbar¹, Eckhard Weber², Frank Kolbinger³, Friedrich Raulf², Olivier Leupin⁴, Shea Carter⁴, Nicolau Beckmann⁴, Linda Mindeholm³, Iain B. McInnes^5,6 and Matthias Schieker³, ¹Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, ²Novartis Institutes for Biomedical Research, Basel,, Switzerland, ³Novartis Institutes for Biomedical Research, Basel, Switzerland, ⁴Novartis Institutes for Biomedical Research, Basel,, United Kingdom, ⁵University of Glasgow, Glasgow, United Kingdom, ⁶Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Great Britain
Background/Purpose: , Shoulder tendinopathy is a multifactorial disorder that accounts for a high proportion (approx. 30%) of referrals to orthopaedic surgeons. Experimental evidence points to…
Abstract Number: 405 • 2018 ACR/ARHP Annual Meeting
Feasibility of Enabling Self-Management and Coping with Arthritic Pain Using Exercise (ESCAPE-Pain) Programme for Knee Osteoarthritis in Malaysia
Muhammad Kamil Che Hasan^1,2, Emma Stanmore² and Chris Todd², ¹Kulliyyah (Faculty) of Nursing, International Islamic University Malaysia (IIUM), Kuantan Pahang, Malaysia, ²Division of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, United Kingdom
Background/Purpose: In Malaysia around one in ten older people are diagnosed with osteoarthritis (OA), with the knee being one of the most commonly affected areas.…
Abstract Number: 406 • 2018 ACR/ARHP Annual Meeting
Limiting the Risk of Osteoarthritis after Anterior Cruciate Ligament Injury: Are We Missing the Opportunity to Intervene?
Aileen Davis¹, Rosalind Wong², Krista Steinhart², Janie Astephen Wilson³, Laura Cruz⁴, David Cudmore³, Tim Dwyer⁵, Linda Li⁶, Peter MacDonald⁷, Paul Marks⁴, Laura Nimmon⁸, Darrell Ogilvie-Harris⁴, Nathan Urquhart³ and Jas Chahal⁵, ¹Health Care and Outcomes Research, Krembil Research Institute, University Health Network, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ²Krembil Research Institute, Health Care and Outcomes Research, Toronto, ON, Canada, ³Dalhousie University, Halifax, NS, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Orthopaedics, University of Toronto, Toronto, ON, Canada, ⁶Arthritis Research Canada, Richmond, BC, Canada, ⁷Pan Am Clinic, Winnipeg, ON, Canada, ⁸University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Fifty percent of people with anterior cruciate (ACL) injury develop knee osteoarthritis (OA) within 6-10 years, even with ligament reconstruction. Despite evidence that targeted…
Abstract Number: 407 • 2018 ACR/ARHP Annual Meeting
Digital Disruptive Technology for Rehabilitation Following Elective Surgery for Low Back Pain, Knee and Hip Osteoarthritis: A Systematic Review and Meta-Analysis
Xia Wang¹, Manuela Ferreira¹, David J. Hunter², Giovana Vesentini³ and Daniel Pozzobon¹, ¹Institute of Bone and Joint Research, University of Sydney, Sydney, Australia, ²Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ³Department of Obstetrics and Gynecology, São Paulo State University, Sydney, Australia
Background/Purpose: The global uptake of digital health technologies in rehabilitation is increasing, but their effectiveness warrants further investigation. We aim to evaluate the effects of…
Abstract Number: 408 • 2018 ACR/ARHP Annual Meeting
State or Trait: Pain Catastrophizing and Widespread Pain Following TKR and Their Associations with Pain Relief
Emma Lape¹, Faith Selzer^1,2, Jamie E. Collins^3,4, Elena Losina^1,4 and Jeffrey N. Katz^1,4, ¹Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ²Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, ³Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ⁴Harvard Medical School, Boston, MA
Background/Purpose: Pain catastrophizing and widespread pain (WP) —constructs reflecting cognitive processes during the pain experience—predict disability, pain chronicity/severity, and lower quality of life in a…
Abstract Number: 409 • 2018 ACR/ARHP Annual Meeting
Unique Skeletal Muscle Relaxant Tolperisone in a Crossover Driving Simulation Study: No Evidence of Sedation Compared to Cyclobenzaprine and Placebo
Judy Caron¹, Thomas Wessel² and Gary Kay³, ¹Drug Development, Neurana Pharmaceuticals, San Diego, CA, ²Medical, Neurana Pharmaceuticals, San Diego, CA, ³Drug Development, Cognitive Research Corporation, St Petersburg, FL
Background/Purpose: Tolperisone is a centrally-acting muscle relaxant being developed in the US as a treatment for acute and painful symptoms of neck and low back…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].